Matthew Lumley

Matthew is a trained Cardiologist with a Ph.D. in cardiovascular physiology. He has extensive experience in the Bio-pharmaceutical field, with positions at Pfizer, as Medical Director of Rare Diseases and, more recently Moderna, where he was responsible for taking the first mRNA therapeutics for rare diseases into the clinic. Currently, Matthew is a Venture Partner at Medicxi.